Comparative Outcomes of First-Line Chemotherapy for Metastatic Pancreatic Cancer Among the Regimens Used in Japan

202216 citationsReviewgold Open Access

Authors

Yuki Takumoto · National Institute of Public Health

Yuriko Sasahara · Yamagata Prefectural Central Hospital

Hiroto Narimatsu · Kanagawa Cancer Center

Manabu Akazawa · Meiji Pharmaceutical University

Abstract

The results of this network meta-analysis support the relative short-term and long-term outcomes associated with first-line chemotherapy for metastatic pancreatic cancer used clinically in Japan.

Topics & Keywords

Pancreatic and Hepatic Oncology Research Cancer Genomics and Diagnostics Renal cell carcinoma treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA Network Open

Volume 5, Issue 1, pp. e2145515-e2145515

DOI: 10.1001/jamanetworkopen.2021.45515

Field-Weighted Citation Impact: 1.68